Table 2 Antimicrobial susceptibility testing of 155 P. aeruginosa isolates (%)
Susceptibility testing | |||
|---|---|---|---|
Antibacterial | Susceptible (%) | Intermediate (%) | Resistant (%) |
Colistin § | 147 (94.9) | 0 | 8 (5.1) |
Meropenem | 110 (70.9) | 9 (5.8) | 39 (25.1) |
Piperacillin | 94 (60.6) | 20 (12.9) | 41 (26.5) |
Amikacin | 93 (60) | 4 (2.6) | 58 (37.4) |
Levofloxacin | 93 (60) | 17 (10.9) | 76 (49.1) |
Tobramycin | 86 (55.5) | 5 (3.2) | 64 (41.3) |
Gentamicin | 84 (54.2) | 6 (3.8) | 65 (41.9) |
Ceftazidime | 81 (52.2) | 0 (0) | 74 (47.7) |
Cefepime | 78 (50.3) | 3 (1.9) | 74 (47.7) |
Ciprofloxacin † | 54 (34.8) | 25 (16.1) | 76 (49.1) |